Bridgeway Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-37,000
| Closed | -$248K | – | 1398 |
|
|
2022
Q3 | $248K | Sell |
37,000
-70,000
| -65% | -$469K | 0.01% | 1092 |
|
|
2022
Q2 | $681K | Hold |
107,000
| – | – | 0.02% | 808 |
|
|
2022
Q1 | $496K | Buy |
+107,000
| New | +$496K | 0.01% | 939 |
|
|
2015
Q2 | – | Sell |
-15,200
| Closed | -$1.41M | – | 1504 |
|
|
2015
Q1 | $1.41M | Sell |
15,200
-17,000
| -53% | -$1.57M | 0.03% | 657 |
|
|
2014
Q4 | $1.3M | Sell |
32,200
-3,300
| -9% | -$133K | 0.03% | 686 |
|
|
2014
Q3 | $868K | Buy |
35,500
+9,800
| +38% | +$240K | 0.02% | 806 |
|
|
2014
Q2 | $407K | Buy |
25,700
+700
| +3% | +$11.1K | 0.01% | 1178 |
|
|
2014
Q1 | $378K | Buy |
+25,000
| New | +$378K | 0.01% | 1191 |
|